Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $27.59 in the prior trading day, Kiniksa Pharmaceuticals International Plc. (NASDAQ: KNSA) closed at $23.26, down -15.68%. In other words, the price has decreased by -$15.68 from its previous closing price. On the day, 0.98 million shares were traded. KNSA stock price reached its highest trading level at $25.36 during the session, while it also had its lowest trading level at $20.2552.
Ratios:
Our goal is to gain a better understanding of KNSA by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.58 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 54.68. For the most recent quarter (mrq), Quick Ratio is recorded 3.16 and its Current Ratio is at 3.57. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on September 13, 2024, initiated with a Buy rating and assigned the stock a target price of $40.
On May 03, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $34.
BofA Securities reiterated its Buy rating for the stock on June 29, 2020, while the target price for the stock was revised from $25 to $40.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 15 ’24 when Tessari Eben sold 17,000 shares for $26.87 per share. The transaction valued at 456,790 led to the insider holds 109,975 shares of the business.
Tessari Eben bought 17,000 shares of KNSA for $456,789 on Oct 15 ’24. On Sep 23 ’24, another insider, Tessari Eben, who serves as the CHIEF OPERATING OFFICER of the company, sold 17,500 shares for $24.99 each. As a result, the insider received 437,325 and left with 116,975 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KNSA now has a Market Capitalization of 1965613312 and an Enterprise Value of 1758258048. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.89 while its Price-to-Book (P/B) ratio in mrq is 3.80. Its current Enterprise Value per Revenue stands at 5.188 whereas that against EBITDA is -69.043.
Stock Price History:
Over the past 52 weeks, KNSA has reached a high of $28.15, while it has fallen to a 52-week low of $14.12. The 50-Day Moving Average of the stock is -9.24%, while the 200-Day Moving Average is calculated to be 8.17%.
Shares Statistics:
The stock has traded on average 367.82K shares per day over the past 3-months and 303950 shares per day over the last 10 days, according to various share statistics. A total of 71.24M shares are outstanding, with a floating share count of 38.75M. Insiders hold about 45.61% of the company’s shares, while institutions hold 50.86% stake in the company. Shares short for KNSA as of 1728950400 were 4006718 with a Short Ratio of 10.89, compared to 1726185600 on 4636433. Therefore, it implies a Short% of Shares Outstanding of 4006718 and a Short% of Float of 12.78.
